8 Sands Capital Mirati Therapeutics Trades
The first Mirati Therapeutics trade was made in Q2 2019. Since then Sands Capital bought shares two more times and sold shares on five occasions. The investor completely sold their stake between Q2 2020 and Q1 2021.
Avg closing price
Price range
Sold -788 Thousand shares
Q1 2021
Avg closing price
$197.99
Price range
$158.92
-
$221.61
Sold 40.8% shares (-543 Thousand shares)
Q4 2020
Avg closing price
$216.19
Price range
$162.05
-
$240.27
Sold 38.6% shares (-838 Thousand shares)
Q3 2020
Avg closing price
$136.84
Price range
$113.26
-
$167.27
Sold 3.5% shares (-79.4 Thousand shares)
Q2 2020
Avg closing price
$96.98
Price range
$72.01
-
$120.39
Increased shares by 24.8% (+446 Thousand shares)
Q1 2020
Avg closing price
$89.68
Price range
$69.78
-
$116.21
Increased shares by 35.4% (+471 Thousand shares)
Q4 2019
Avg closing price
$96.45
Price range
$70.76
-
$128.86
Sold 3.5% shares (-48.6 Thousand shares)
Q3 2019
Avg closing price
$93.85
Price range
$77.91
-
$109.60
New holding (+1.38 Million shares)
Q2 2019
Avg closing price
$77.85
Price range
$59.49
-
$104.71
